Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · April 13, 2024

Dosing Patterns of Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Ravulizumab in the US

Advances in Therapy


Additional Info

Disclosure statements are available on the authors' profiles:

Advances in Therapy
Dosing Patterns of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab in the United States: A Retrospective Claims-Based Analysis
Adv Ther 2024 Jan 01;41(1)413-430, WY Cheng, J Fishman, M Yenikomshian, M Mahendran, C Kunzweiler, JD Vu, MS Duh

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading